BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 12571784)

  • 1. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
    Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
    Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
    Berghuis B; van der Palen J; de Haan GJ; Lindhout D; Koeleman BPC; Sander JW;
    Epilepsia; 2017 Jul; 58(7):1227-1233. PubMed ID: 28542738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia from oxcarbazepine and carbamazepine.
    Dong X; Leppik IE; White J; Rarick J
    Neurology; 2005 Dec; 65(12):1976-8. PubMed ID: 16380624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
    Berghuis B; Hulst J; Sonsma A; McCormack M; de Haan GJ; Sander JW; Lindhout D; Koeleman BPC
    Epilepsia; 2021 Mar; 62(3):778-784. PubMed ID: 33576502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatremic coma under oxcarbazepine therapy.
    Steinhoff BJ; Stoll KD; Stodieck SR; Paulus W
    Epilepsy Res; 1992 Mar; 11(1):67-70. PubMed ID: 1563340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy.
    Ortenzi A; Paggi A; Foschi N; Sabbatini D; Pistoli E
    Funct Neurol; 2008; 23(2):97-100. PubMed ID: 18671911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
    Schmidt D; Elger CE
    Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of serum sodium after replacing carbamazepine with oxcarbazepine.
    Isojärvi JI; Huuskonen UE; Pakarinen AJ; Vuolteenaho O; Myllylä VV
    Epilepsia; 2001 Jun; 42(6):741-5. PubMed ID: 11422328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia.
    Kim YS; Kim DW; Jung KH; Lee ST; Kang BS; Byun JI; Yeom JS; Chu K; Lee SK
    Seizure; 2014 Mar; 23(3):208-12. PubMed ID: 24378204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxcarbazepine on sodium concentration and water handling.
    Sachdeo RC; Wasserstein A; Mesenbrink PJ; D'Souza J
    Ann Neurol; 2002 May; 51(5):613-20. PubMed ID: 12112108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients.
    Intravooth T; Staack AM; Juerges K; Stockinger J; Steinhoff BJ
    Epilepsy Res; 2018 Jul; 143():7-10. PubMed ID: 29631131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxcarbazepine in the treatment of epilepsy. A review and update].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia.
    Berghuis B; de Haan GJ; van den Broek MP; Sander JW; Lindhout D; Koeleman BP
    Eur J Neurol; 2016 Sep; 23(9):1393-9. PubMed ID: 27333872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
    Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
    Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatremia induced by oxcarbazepine in children.
    Borusiak P; Korn-Merker E; Holert N; Boenigk HE
    Epilepsy Res; 1998 May; 30(3):241-6. PubMed ID: 9657651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxcarbazepine].
    Arroyo S
    Neurologia; 2001 Oct; 16(8):370-5. PubMed ID: 11738014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical recommendations for oxcarbazepine.
    Smith PE;
    Seizure; 2001 Mar; 10(2):87-91. PubMed ID: 11421225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.
    Löfgren E; Tapanainen JS; Koivunen R; Pakarinen A; Isojärvi JI
    Epilepsia; 2006 Sep; 47(9):1441-6. PubMed ID: 16981858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.